Back to Search
Start Over
Decision Models and Technology Can Help Psychiatry Develop Biomarkers.
- Source :
-
Frontiers in psychiatry [Front Psychiatry] 2021 Sep 09; Vol. 12, pp. 706655. Date of Electronic Publication: 2021 Sep 09 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Why is psychiatry unable to define clinically useful biomarkers? We explore this question from the vantage of data and decision science and consider biomarkers as a form of phenotypic data that resolves a well-defined clinical decision. We introduce a framework that systematizes different forms of phenotypic data and further introduce the concept of decision model to describe the strategies a clinician uses to seek out, combine, and act on clinical data. Though many medical specialties rely on quantitative clinical data and operationalized decision models, we observe that, in psychiatry, clinical data are gathered and used in idiosyncratic decision models that exist solely in the clinician's mind and therefore are outside empirical evaluation. This, we argue, is a fundamental reason why psychiatry is unable to define clinically useful biomarkers: because psychiatry does not currently quantify clinical data, decision models cannot be operationalized and, in the absence of an operationalized decision model, it is impossible to define how a biomarker might be of use. Here, psychiatry might benefit from digital technologies that have recently emerged specifically to quantify clinically relevant facets of human behavior. We propose that digital tools might help psychiatry in two ways: first, by quantifying data already present in the standard clinical interaction and by allowing decision models to be operationalized and evaluated; second, by testing whether new forms of data might have value within an operationalized decision model. We reference successes from other medical specialties to illustrate how quantitative data and operationalized decision models improve patient care.<br />Competing Interests: SH was employed by company T. J. Watson IBM Research Laboratory. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Barron, Baker, Budde, Bzdok, Eickhoff, Friston, Fox, Geha, Heisig, Holmes, Onnela, Powers, Silbersweig and Krystal.)
Details
- Language :
- English
- ISSN :
- 1664-0640
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 34566711
- Full Text :
- https://doi.org/10.3389/fpsyt.2021.706655